Small cell lung cancer (SCLC) is an aggressive tumor and prognosis remains dismal. Screening for the targetable driver mutations of this malignant tumor contributes to improve the therapeutic approaches and outcome. This review will report the advances on some latest driver mutations
The adenocarcinoma of the lung has recently shown peculiar molecular characteristics, which relate w...
Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and mol...
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis. We sequenced ...
Small cell lung cancer (SCLC) is a highly proliferative lung cancer that is not amenable to surgery ...
Although the incidence of small cell lung cancer (SCLC) has declined during the past 30 years, it re...
Small cell lung cancer (SCLC) comprises about 15% of all lung cancers. It is an aggressive disease, ...
Lung cancer is the leading cause of cancer-related mortality and will affect ∼6% of the population. ...
Small cell lung cancer (SCLC) arises in peribronchial locations and infiltrates the bronchial submuc...
Background. Small cell lung cancer (SCLC) is an aggressive and invasive malignancy that presents at ...
Background and objective Lung cancer is the leading cause of cancer-related deaths worldwide. Next t...
The adenocarcinoma of the lung has recently shown peculiar molecular characteristics, which relate w...
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that is characterized by a rapid ...
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis. We sequenced ...
Small cell lung cancer (SCLC) is characterized by aggressive tumor biology with a high proliferation...
ABSTRACT: Small-cell lung cancer (SCLC) accounts for roughly 15% of all lung malignancies and is dis...
The adenocarcinoma of the lung has recently shown peculiar molecular characteristics, which relate w...
Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and mol...
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis. We sequenced ...
Small cell lung cancer (SCLC) is a highly proliferative lung cancer that is not amenable to surgery ...
Although the incidence of small cell lung cancer (SCLC) has declined during the past 30 years, it re...
Small cell lung cancer (SCLC) comprises about 15% of all lung cancers. It is an aggressive disease, ...
Lung cancer is the leading cause of cancer-related mortality and will affect ∼6% of the population. ...
Small cell lung cancer (SCLC) arises in peribronchial locations and infiltrates the bronchial submuc...
Background. Small cell lung cancer (SCLC) is an aggressive and invasive malignancy that presents at ...
Background and objective Lung cancer is the leading cause of cancer-related deaths worldwide. Next t...
The adenocarcinoma of the lung has recently shown peculiar molecular characteristics, which relate w...
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that is characterized by a rapid ...
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis. We sequenced ...
Small cell lung cancer (SCLC) is characterized by aggressive tumor biology with a high proliferation...
ABSTRACT: Small-cell lung cancer (SCLC) accounts for roughly 15% of all lung malignancies and is dis...
The adenocarcinoma of the lung has recently shown peculiar molecular characteristics, which relate w...
Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and mol...
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis. We sequenced ...
DOI
Add to ORKG